StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.61−0.19 (-3.96%)

Close on Nov 17, 2026Market cap $57.89MP/E –Yield –

Neuraxis enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Neuraxis's enterprise value was $66.90M on Nov 11, 2026, against $23.30M a year earlier. Over the last 3 years it ranged from $5.22M to $83.61M, with a median of $21.41M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$66.90M+64.4%
2025Dec 31, 2025$40.70M+149.9%
2024Dec 31, 2024$16.29M+23.6%
2023Dec 29, 2023$13.18M–

More Neuraxis figures

See a number that looks wrong?